MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Study of Intermittent Positive Pressure Breathing (IPPB)

Phase 3
Completed
Conditions
Lung Diseases
Chronic Obstructive Pulmonary Disease
Lung Diseases, Obstructive
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000565

Cord Blood Stem Cell Transplantation Study (COBLT)

Phase 2
Completed
Conditions
Hematologic Diseases
Hematopoietic Stem Cell Transplantation
Myelodysplastic Syndromes
Anemia, Aplastic
Fanconi Anemia
Leukemia
Severe Combined Immunodeficiency
Neoplasms
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000603

Trials of Hypertension Prevention (TOHP)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
Vascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000528

Stress Reduction and Atherosclerotic CVD in Blacks

Phase 3
Completed
Conditions
Heart Diseases
Hypertension
Cardiovascular Diseases
Coronary Disease
Vascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000546

Post Coronary Artery Bypass Graft (CABG) Study

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000463

Multicenter Unsustained Tachycardia Trial (MUSTT)

Phase 3
Completed
Conditions
Arrhythmia
Cardiovascular Diseases
Coronary Disease
Death, Sudden, Cardiac
Heart Diseases
Myocardial Ischemia
Tachycardia, Ventricular
First Posted Date
1999-10-28
Last Posted Date
2017-01-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000480

Postmenopausal Estrogen/Progestin Interventions (PEPI)

Phase 3
Completed
Conditions
Bone Diseases
Thrombosis
Postmenopause
Cardiovascular Diseases
Coronary Disease
Diabetes Mellitus
Heart Diseases
Hypercholesterolemia
Hypertension
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-05-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000466

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

Phase 3
Completed
Conditions
Atrial Fibrillation
Cardiovascular Diseases
Arrhythmia
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000556

Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)

Phase 3
Completed
Conditions
Heart Diseases
Cardiovascular Diseases
Coronary Disease
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000488

CVD Risk and Health in Postmenopausal Phytoestrogen Users

Phase 2
Completed
Conditions
Bone Diseases
Cardiovascular Diseases
Coronary Disease
Myocardial Ischemia
Postmenopause
Depression
Heart Diseases
Osteoporosis
First Posted Date
1999-10-28
Last Posted Date
2016-02-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000613
© Copyright 2025. All Rights Reserved by MedPath